AARD vs MBX โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
MBX Captures Institutional Edge (2โ1 Pillars ยท 4โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to MBX Biosciences, Inc. Common Stock (MBX) driven by superior Growth & Margin, Momentum & Technical while AARD counters with relative strength in Options & Structure. Fundamentally, AARD trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus MBX at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, AARD sits in UNCLASSIFIED (26th %ile IV; Dealer Gamma Walls on Pro) against MBX sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | AARD | MBX | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $29.1M | $2.8B | Larger Scale | MBX |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +0.0% | +0.0% | Higher Growth | Tie |
| Operating Margin (TTM) Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -66.0% | -33.7% | Higher ROE | MBX |
| 52-Week Range Position Momentum | 2% ($1โ$17) | 61% ($23โ$73) | Stronger Trend | MBX |
| Beta / 30D Volatility Risk Regime | 4.10ฮฒ ยท 288% Vol | 1.58ฮฒ ยท 66% Vol | Lower Realized Risk | MBX |
| Unified Institutional Score Composite Signal | 57.5 / 100 (HOLD) | 44.9 / 100 (HOLD) | Higher Composite | AARD |